![]() | Up a level |
Zijlstra, Josee M, Follows, George, Casasnovas, Rene-Olivier, Vermaat, Joost SP, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360, Choquet, Sylvain, Hill, Brian, Thieblemont, Catherine, Cavallo, Federica, Cruz, Fatima De la et al (show 20 more authors)
(2022)
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.
CANCERS, 14 (3).
791-.
Maerevoet, Marie, Zijlstra, Josee M, Follows, George, Casasnovas, Rene-Olivier, Vermaat, JSP, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360, Goy, Andre, Choquet, Sylvain, Van den Neste, Eric, Hill, Brian et al (show 24 more authors)
(2021)
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
JOURNAL OF HEMATOLOGY & ONCOLOGY, 14 (1).
111-.